Pharmacokinetic modelling of P-glycoprotein function at the blood-brain barrier with [18F]MC225 PET in non-human primates

被引：0
|
作者：
Varela, L. Garcia [1 ]
Arif, W. M. [1 ]
Garcia, D. Vallez [1 ]
Kakiuchi, T. [2 ]
Ohba, H. [2 ]
Nishiyama, S. [2 ]
Tago, T. [3 ]
Elsinga, P. H. [1 ]
Tsukada, H. [2 ]
Colabufo, N. A. [4 ]
Dierckx, R. A. J. O. [1 ]
van Waarde, A. [1 ]
Toyohara, J. [3 ]
Boellaard, R. [1 ]
Luurtsema, G. [1 ]
机构：
[1] Univ Groningen, Groningen, Netherlands
[2] Hamamatsu Photon KK, Cent Res Lab, Hamamatsu, Shizuoka, Japan
[3] Tokyo Metropolitan Inst Gerontol, Res Team Neuroimaging, Tokyo, Japan
[4] Univ Bari Aldo Moro, Bari, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2019年 / 46卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-662
引用
收藏
页码：S252 / S252
页数：1
相关论文
共 50 条
  • [41] Inhibition of P-Glycoprotein Function by Procyanidine on Blood-Brain Barrier
    He, Ling
    Zhao, Chuan
    Yan, Ming
    Zhang, Lu-Yong
    Xia, Yuan-Zheng
    PHYTOTHERAPY RESEARCH, 2009, 23 (07) : 933 - 937
  • [42] Imaging P-glycoprotein at the human blood-brain barrier - Reply
    Unadkat, Jashvant D.
    Link, Jeanne M.
    Mankoff, David A.
    Muzi, Mark
    Collier, Ann C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 80 (03) : 303 - 304
  • [43] ON THE ROLE OF P-GLYCOPROTEIN FUNCTION IN THE BLOOD-BRAIN BARRIER IN PHARMACORESISTANCE: A PET STUDY IN EPILEPTIC RATS
    Voskuyl, R. A.
    Syvanen, S.
    Luurtsema, G.
    Molthoff, C. F.
    Windhorst, A. D.
    Huisman, M. C.
    Lammertsma, A. A.
    de Lange, E. C.
    EPILEPSIA, 2009, 50 : 337 - 337
  • [44] Are there gender differences in P-glycoprotein function at the rat blood-brain barrier ?
    Marie, S.
    Pottier, G.
    Goutal, S.
    Auvity, S.
    Buvat, I.
    Boisgard, R.
    Dolle, F.
    Caille, F.
    Tournier, N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S542 - S543
  • [45] P-Glycoprotein Function at the Blood-Brain Barrier: Effects of Age and Gender
    van Assema, Danielle M. E.
    Lubberink, Mark
    Boellaard, Ronald
    Schuit, Robert C.
    Windhorst, Albert D.
    Scheltens, Philip
    Lammertsma, Adriaan A.
    van Berckel, Bart N. M.
    MOLECULAR IMAGING AND BIOLOGY, 2012, 14 (06) : 771 - 776
  • [46] Can P-glycoprotein at the human blood-brain barrier be induced by rifampin? A PET imaging study
    Liu, Li
    Collier, Ann C.
    Link, Jeanne M.
    Domino, Karen B.
    Eary, Janet F.
    Mankoff, David A.
    Hsiao, Peng
    Deo, Anand K.
    Unadkat, Jashvant D.
    DRUG METABOLISM REVIEWS, 2011, 43 : 30 - 31
  • [47] Blood-brain barrier P-glycoprotein function in Alzheimer's disease
    van Assema, Danielle M. E.
    Lubberink, Mark
    Bauer, Martin
    van der Flier, Wiesje M.
    Schuit, Robert C.
    Windhorst, Albert D.
    Comans, Emile F. I.
    Hoetjes, Nikie J.
    Tolboom, Nelleke
    Langer, Oliver
    Mueller, Markus
    Scheltens, Philip
    Lammertsma, Adriaan A.
    van Berckel, Bart N. M.
    BRAIN, 2012, 135 : 181 - 189
  • [48] Differences in P-glycoprotein activity in human and rodent blood-brain barrier assessed by mechanistic modelling
    Verscheijden, Laurens F. M.
    Koenderink, Jan B.
    de Wildt, Saskia N.
    Russel, Frans G. M.
    ARCHIVES OF TOXICOLOGY, 2021, 95 (09) : 3015 - 3029
  • [49] Pharmacokinetic Characterization of [18F]3F4AP in non-human primates
    Guehl, Nicolas
    Ramos-Torres, Karla
    Wilks, Moses
    Dhaynaut, Maeva
    Moon, Sung-Hyun
    El Fakhri, Georges
    Normandin, Marc
    Brugarolas, Pedro
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [50] Inflammatory mediators alter P-glycoprotein function and expression at the blood-brain barrier
    Hartz, AMS
    Bauer, B
    Fricker, G
    Miller, DS
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2005, 371 : R2 - R2
12345